Sandhill Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Hold
14,021
0.11% 53
2025
Q4
$1.26M Hold
14,021
0.09% 58
2025
Q3
$1.38M Sell
14,021
-374
-3% -$37.1K 0.1% 55
2025
Q2
$1.31M Hold
14,395
0.09% 55
2025
Q1
$1.63M Hold
14,395
0.13% 53
2024
Q4
$1.52M Sell
14,395
-27
-0.2% -$2.9K 0.12% 55
2024
Q3
$1.56M Sell
14,422
-52
-0.4% -$5.67K 0.11% 55
2024
Q2
$1.57M Sell
14,474
-96
-0.7% -$11.3K 0.12% 57
2024
Q1
$1.92M Sell
14,570
-272,124
-95% -$34M 0.15% 53
2023
Q4
$34.9M Sell
286,694
-56,556
-16% -$6.31M 2.9% 16
2023
Q3
$38.5M Buy
343,250
+84,893
+33% +$10.8M 3.6% 12
2023
Q2
$37.6M Sell
258,357
-25,647
-9% -$3.49M 3.43% 11
2023
Q1
$36.7M Sell
284,004
-1,780
-0.6% -$223K 3.52% 12
2022
Q4
$36.4M Sell
285,784
-57,083
-17% -$6.62M 3.89% 7
2022
Q3
$35.8M Sell
342,867
-19,032
-5% -$2.09M 4.09% 5
2022
Q2
$38M Sell
361,899
-33,993
-9% -$4.03M 4.06% 4
2022
Q1
$50.6M Buy
+395,892
New +$47.7M 4.35% 3

Other funds holding ZBH

Sandhill Capital Partners's ZBH Position: Q1 2026 in Review

Sandhill Capital Partners held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 14,021 shares worth $1.27M. The position accounts for 0.11% of the portfolio, ranked #53.

Sandhill Capital Partners first reported a position in ZBH in Q1 2022 and has held it in 17 quarters since. The position peaked at $50.6M in Q1 2022. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Sandhill Capital Partners held 14,021 shares of Zimmer Biomet worth $1.27M as of Q1 2026.
  • Sandhill Capital Partners left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.11% of Sandhill Capital Partners's portfolio in Q1 2026, its #53 holding.
  • Sandhill Capital Partners first reported a position in Zimmer Biomet in Q1 2022 and has held it in 17 quarters since.
  • Sandhill Capital Partners's Zimmer Biomet position peaked at $50.6M in Q1 2022.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Sandhill Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.